Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Eye Diseases

• Efficacy of a New Nanoemulsion Artificial Tear in Dry Eye Disease Management
• An Open-label Study for Participants Who Are Non-responders at the End of Treatment Assessment on the VRDN-001-101 and VRDN-001-301 Pivotal Studies
• Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)
• Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers
• Low Dose Atropine for Symptomatic Vitreous Floaters
• Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia
• A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease
• A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
• A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease (SatraGO-2)
• Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease
• A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 75 Years of Age With Thyroid Eye Disease
• Efficacy and Safety of Tocilizumab for TAO
• Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
• A Randomized, Double-masked, Placebo-controlled Safety, Tolerability, and Efficacy Study of VRDN-001, a Humanized Monoclonal Antibody Directed Against the IGF-1 Receptor, in Participants With Chronic Thyroid Eye Disease (TED)
• Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
• A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease
• Improving Drop Instillation Comfort of a Cyclosporine A Solution
• Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia
• Safety and Efficacy of Licaminlimab Ophthalmic Suspension for the Treatment of Dry Eye Disease
• Diamond Bur Microblepharoexfoliation, Intense Pulse Light and Meibomian Gland Expression for Evaporative Dry Eye
• Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
• Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease
• OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)
• Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease
• Study of ZB001 in Chinese Patients With Thyroid Eye Disease
• The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
• Phase 3 Safety Study for the Treatment of Presbyopia Subjects
• A Study of TL-925 as a Treatment for Dry Eye Disease
• HU007 in Patients With Dry Eye Syndrome
• Safety and Efficacy of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops Treatment for Dry Eye Diseases Post Refractive Surgery and Associated With Blepharospasm
• Phase II Clinical Trial to Evaluate the Efficacy and Safety of SCAI-001 Eye Drops in Patients With Dry Eye Disease
• Phase 3 Efficacy Study in the Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia
• Effects of NOV03 on the Tear Film
• Nasal Spray Study in Sjogren's Dry Eye Disease
• Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Subjects With Dry Eye.
• Efficacy and Safety of VB421 in Subjects With Thyroid Eye Disease (TED)
• Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
• Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia
• A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune Disease
• Safety, Tolerability and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
• Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease
• Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.
• Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
• Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease
• Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
• Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction
• A Randomized, Controlled, Double-masked, Investigator-initiated Trial to Evaluate Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray
• Study Evaluating Techniques for Measuring Tear Production
• A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512
• Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Placebo in Participants With Dry Eye Disease.
• Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia
• A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye Disease
• A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
• A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
• Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease
• A Study of AG-80308 in Dry Eye Patients
• Double-masked Controlled Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease
• Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)
• Comparison of Two Types of Artificial Tears
• Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients
• Safety Study of Tivanisiran to Treat Dry Eye
• Effect of Repeated Low-Level Red-Light Therapy on Visual Field Damage in Primary Open-angle Glaucoma
• Evaluation of the Efficacy and Safety of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia
• Study Evaluating the Safety and Efficacy of AR-15512
• A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
• Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients
• Study of ST-100 as Treatment for Dry Eye Disease
• A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
• Concentration of Ofloxacin Into the Aqueous Humour of Patients With Dry Eye Disease
• A Study of Laquinimod Eye-drops in Healthy Participants
• Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)
• A Safety, Tolerability and Efficacy Study of VRDN 001 in Healthy Volunteers and Persons With Thyroid Eye Disease (TED)
• Effectiveness of Periocular Drug Injection in CATaract Surgery
• Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Advanced Vision Loss (Sirius)
• IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL
• Study to Evaluate Safety and Efficacy of Oxervate® Ophthalmic Solution vs Vehicle in Severe Sjogren's Dry Eye Disease
• Hydroxychloroquine in Graves' Orbitopathy
• Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream (4%, 6%, 8%)
• Multi-model Image of Doxycycline in TAO
• Multi-model Image of Immunosuppressive Agents in TAO
• An Exploratory Clinical Trial to Assess Safety and Tolerability in Subjects With Dry Eye Disease
• Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)
• The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
• Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)
• Efficacy of Xiidra in Dry Eye Disease After Collagen Cross Linking
• Evaluation of the Safety, Tolerability and Efficacy of iNexin™ for the Treatment of the Signs and Symptoms Associated With Dry Eye Disease
• Evaluation of Lacrimal Punctal Changes by Anterior Segment Optical Coherence Tomography AS-OCT After Topical Combined Antibiotics and Steroids Treatment in Cases of Inflammatory Punctual Stenosis
• A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease
• TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study
• A Clinical Trial to Assess Subjects With Dry Eye Disease.
• Corneal Thickness Changes in Patient Undergoing Dry Eye Managment
• Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease
• ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease
• Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction
• Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
• Tocilizumab in Active Moderate-severe Graves' Orbitopathy
• An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.
• Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
• Prospective, Randomized, Masked, Controlled Trial To Evaluate The Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)
• The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease
• Effect of Traditional Chinese Medicine on Basic Tear Secretion and Tear Cytokines in Patients With Dry Eye Disease
• Study to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Palovarotene Ophthalmic Solution in Healthy Adult Subjects
• To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye Disease
• A Study of the Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED)
• A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
• A Research Study to See How Well an Eye Drop, SURF-200 (0.02% and 0.04% Betamethasone Sodium Phosphate), Works, What Side Effects There Are, and to Compare it With Vehicle (Placebo) in Subjects Diagnosed With Dry Eye Disease and Experiencing An Epis
• A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
• Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery
• Comparison of Efficacy Between 100% Platelet-rich Plasma and 100% Serum Eye Drops in Dry Eye Disease
• Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease
• The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
• Study on Curative Effect and Mechanism of Acupuncture on Neuropathic Pain in Dry Eye Disease
• Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
• Safety and Efficacy of Two Different Concentrations (0.5% and 1%) of Progesterone Topical Gel Compared to Placebo in Patients Diagnosed With Moderate to Severe Dry Eye Syndrome
• Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome
• Sirolimus for Graves' Orbitopathy (GO)
• A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease
• Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)
• Study of VVN001 Ophthalmic Solution in Dry Eye Disease
• Study to Evaluate the Efficacy and Safety of CKD-352
• Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO
• Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
• Study to Evaluate the Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (SDP-4-CS202)
• Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy
• Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED)
• Brinzolamide-brimonidine Fixed Combination for Preventing IOP Elevation After Intravitreal Anti-VEGF Injections
• CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004
• ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
• OSIG-eye Drops Treatment for Dry Eye Disease
• A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease
• Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)
• A Randomized Study of Smile Exercise for Dry Eye
• Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye Disease
• Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye Disease
• Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
• A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease
• Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.
• Tamsulosin for Thyroid Lid Retraction
• Effect of Cequa™ in Subjects With Dry Eye Disease
• Anti-VEGF Therapy for Acute Thyroid Eye Disease
• Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye
• Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease
• Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
• FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial
• 3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)
• Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)
• Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study)
• Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
• Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients
• Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
• A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
• Liposomal Sirolimus in Dry Eye Disease
• A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
• Evaluating the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Dry Eye Disease
• A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
• IVIG-eye Drops Treatment for Dry Eye Disease
• 99Tc-MDP for Thyroid-Associated Ophthalmopathy
• ASCEND GO-2: Study of RVT-1401 for the Treatment of Patients With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )
• Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy ( GO )
• Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
• A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease
• A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
• Extension Study to Study PQ-110-001 (NCT03140969)
• Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation
• Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)
• Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease
• The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
• Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease
• Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study)
• Single Ascending Dose Study in Participants With LCA10
• Abatacept in Patients With Birdshot HLA A29 Uveitis
• Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO
• Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)
• Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene
• Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.
• Bimatoprost as a Treatment for Graves' Orbitopathy
• Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation (The IMPERIAL Study)
• Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects
• A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)
• Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
• Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The RAINIER Study)
• A Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease (DED)
• Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease
• Tofacitinib for Inflammatory Eye Disease
• A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye Disease
• Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study)
• Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms
• Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers
• Dry Eye Disease Study With Brimonidine
• Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease
• A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
• Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
• Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction
• CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
• Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease
• Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
• Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease
• VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP
• Zoster Eye Disease Study
• Treatment of Graves´Ophthalmopathy With Simvastatin (GO-DS)
• Effects of Atorvastatin in Graves' Orbitopathy (GO)
• HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)
• A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy
• Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
• KJ-TFC-004 Drug-drug Interaction Study
• Celecoxib for Thyroid Eye Disease
• Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
• Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
• Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
• Study for Collection of Aflibercept Data in Routine Practice
• A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
• CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)
• A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.
• Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
• The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy
• The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
• Study of EBI-005 in Dry Eye Disease (DED)
• The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)
• Rituximab (RTX) Therapy in Patients With Active TAO
• Intravitreal Injections by Nurses and Physicians Compared
• X-82 to Treat Age-related Macular Degeneration
• Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
• The Effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness
• Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood
• Topical Diclofenac on Macular Thickness After Phacoemulsification
• A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
• Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
• Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
• Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease
• Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
• Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
• Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues
• Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
• The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED
• The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED
• Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)
• Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)
• A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
• Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
• Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
• A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects
• Phase 3 Study of EBI-005 in Dry Eye Disease
• A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy
• The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
• Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment
• Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL)
• Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease
• Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)
• Systane Ultra Versus Maxidex Versus Saline
• Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
• A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
• Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
• Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
• Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
• A Study of RX-10045 in the Treatment of Dry Eye Disease
• A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease
• Evaluation of Ocular Comfort With ISTA Tears vs Systane
• Safety Study of Lifitegrast to Treat Dry Eye
• Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections
• The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy
• Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
• A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease
• A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
• Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)
• Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)
• Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
• Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy
• Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
• Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients
• Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction
• Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
• Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
• Trial of CF101 to Treat Patients With Dry Eye Disease
• Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)
• A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
• A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
• A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
• Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
• The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy
• A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease
• The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial)
• Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)
• Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)
• The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)
• Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%
• Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
• Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time
• Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease
• A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution
• A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease
• Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease
• Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops
• Effect of Olopatadine on Allergic Tear Mediators
• Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)
• Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome
• Trial of Rituximab for Graves' Ophthalmopathy
• Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
• Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
• Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
• Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy
• Testing of Innocuousness of Benzalkonium Chloride on the Eye Concerning Possible Growth of Langerhans Cells
• Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
• Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
• Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease
• Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
• The Visual Effect of an Investigational Artificial Tear in the Tear Layer.
• Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease
• A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye Disease
• Thyroid Treatment Trial
• Age-Related Eye Disease Study 2 (AREDS2)
• The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes
• Next Generation Ophthalmic Irrigating Solution Posterior Segment Study
• Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
• Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment
• Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
• Rituximab in the Treatment of Graves' Disease
• Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy
• Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation
• Cyclosporin Implant to Treat Uveitis